Attenuated pseudorabies virus with deletion gene and application of attenuated pseudorabies virus as vaccine
A pseudorabies virus and gene deletion technology, which is applied to viruses, vaccines, antiviral agents, etc., can solve problems such as low immunity, unsatisfactory use effects, and unclear safety, and achieve good safety effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1: Design of PRV-specific sgRNA
[0048] Design sgRNAs targeting gE, gl, TK and US3 gene sequences (see Table 1 for design).
[0049] Table 1 CRISPR / Cas9 sgRNA sequences targeting the PRV-GL genome
[0050]
Embodiment 2
[0051] Example 2: Construction of CRISPR / Cas9 vector
[0052] Heat the 2 primers of the 6 groups of sgRNA-gE designed in Example 1 at 95°C for 5 minutes, and cool naturally to anneal to form a double double-stranded structure. The annealed product is cloned into the PX330 vector after digestion with BbsI, and transformed into competent DH5α . The plasmids were extracted from the expanded culture of the correctly sequenced bacterial solution for later use.
Embodiment 3
[0053] Embodiment 3: the acquisition of recombinant virus
[0054] 3 μg of PRV-GL genome and 0.5 μg each of pX330-gE / gI sgRNA1 / 2 plasmids were co-transfected into monolayer VERO cells (6-well plate). Typical cytopathic changes (CPE) can be seen 48 hours after transfection. After 72 hours, the supernatant of the transfected cells was harvested, inoculated with PK-15 cells, and subjected to plaque purification and screening; plaques were picked under a fluorescent microscope, and after 10 rounds of purification , and the obtained virus was named rPRV-delgE / gI. Similarly, 3 μg of the rPRV-delgE / gI genome and each 0.5 μg of the pX330-TKsgRNA1 / 2 plasmid were co-transfected into monolayer VERO cells (6-well plate), and plaque screening was performed again to obtain rPRV-delgE / gI / TK ( triple gene deletion recombinant virus). Finally, rPRV-delgE / gI / TK was co-transfected with pX330-US3 sgRNA1 / 2 to obtain rPRV-delgE / gI / TK / US3 (four-gene deletion recombinant virus).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com